Our goal is to improve cancer patient care by providing oncologists worldwide with the latest advances in genetics, clinical pharmacology, epidemiology, and supportive care. We do this by providing educational content in multiple formats throughout the year.
Create an online account to receive updates on new activities and events, and access your CME Tracker.
Note: Fields with * are required
These activities are sponsored by pmiCME. For a complete listing of CME credits, please refer to the accreditation and designation statement in each individual activity.
Support for these activities has been provided by: AstraZeneca; Bristol-Myers Squibb; Celgene Corporation; Eisai; Genentech BioOncology and Biogen Idec; Genentech BioOncology and OSI Oncology; Genomic Health; Lilly USA, LLC; Millennium, the Takeda Oncology Company; and Novartis Oncology; and sanofi-aventis.
© 2010 M|C Communications, LLC. All other trademarks are the property of their respective owners.
For details on Pri-Med's cancellation policy, visit www.pri-med.com/cancel.
| BREAST CANCER TRACK | |
|---|---|
| DESCRIPTION | FORMAT |
| Harold J. Burstein: Hormone Receptor Positive Breast Cancer: Best Management Practices for Long Term Therapy | Webcast |
| Harold J. Burstein: Early-stage Endocrine-responsive Breast Cancer: Investigating New Options for Premenopausal Women | Expert Perspective |
| Kenneth Offit: Guidelines for Cancer Genetic Testing and Management of Patients with BRCA Hereditary Breast Cancer | Expert Perspective |
| HEMATOLOGIC MALIGNANCIES TRACK | |
|---|---|
| DESCRIPTION | FORMAT |
| Kenneth C. Anderson: Multiple Myeloma: Incorporating Recent Clinical Trial Results into Current Management Practices | Expert Perspective |
| Daniel J. DeAngelo: Chronic Myeloid Leukemia: Effective Choices in Molecular Diagnostics Testing | Expert Perspective |
| Ayalew Tefferi: Mutational Analysis in Myeloproliferative Disorders: Impact on Prognosis and Therapeutic Choices | Expert Perspective |
| Arnold S. Freedman: Current and Emerging Therapeutic Approaches to Diffuse Large B-cell | Expert Perspective |
| Arnold S. Freedman: T-Cell Lymphomas: Available and Emerging Therapeutic Options | Expert Perspective |
| LUNG, HEAD AND NECK CANCER TRACK | |
|---|---|
| DESCRIPTION | FORMAT |
| David G. Pfister: Integrating Local and Systemic Therapies Into the Comprehensive Management of Head and Neck Cancer | Expert Perspective |
| Pasi A. Jänne: EGFR Testing in Non-Small Lung Cancer: Practical Strategies That Incorporate Recent Clinical Advances | Expert Perspective |
| David M. Jackman: T-Cell Lymphomas: Evaluating and Treating Advanced NSCLC in Female With EGFR Mutation | Patient Case Study |
| Robert Haddad: Head and Neck Cancer Update: Combined Treatment Modalities and Comprehensive Management | Webcast |
| Bruce Johnson: Extensive-Stage Small Cell Lung Cancer: Is Irinotecan/Cisplatin a Viable Alternative? | Expert Perspective |
| GASTROINTESTINAL CANCERS TRACK | |
|---|---|
| DESCRIPTION | FORMAT |
| Sapna Syngal: Genetic Syndromes and Gastrointestinal Cancers: A Practical Guide to Identifying and Managing Patients at Risk | Webcast |
| Robert J. Mayer: Clinical Trial Update: Combining Targeted Therapies in Metastatic Colorectal Cancer | Expert Perspective |
| GENITOURINARY CANCER TRACK | |
|---|---|
| DESCRIPTION | FORMAT |
| Toni K. Choueiri: Clinical Decision-Making in Metastatic Renal Cell Carcinoma: Choosing a Targeted Therapy | Expert Perspective |
| Philip W. Kantoff: Advanced and Metastatic Prostate Cancer: Patient Assessment, Current Best Practices and Emerging Therapies | Webcast |
| SUPPORTIVE CARE TRACK | |
|---|---|
| DESCRIPTION | FORMAT |
| Janet L. Abrahm:: Treating Pain in Cancer Patients: Recent Advances and Current Best Practices | Expert Perspective |
| Janet L. Abrahm: Caring for the Whole Patient: Optimizing Treatment of the Physical Psychological and Social Consequences of Cancer | Webcast |